Abstract |
HDN attributed to the rare Rh variants has become more and more significant caused by anti-D, but the compatible blood is usually very difficult to obtain when exchange transfusion is required. We treated a 10-hour neonate of O, D + C + c - E - e+ blood group with severe HDN due to anti-Rh17 with least incompatible blood typed O, D + C - c + E + e-. The neonatal hemolysis was relieved obviously and bilirubin was reduced gradually after exchange transfusion. The infant was discharged in good health 13 days after birth with 135.0 g/L, 28.0 micromol/L and 10.7 micromol/L of Hb, total bilirubin and direct bilirubin, respectively. No sequelae were observed in a three-year follow-up. The result suggesting that the least incompatible blood is an alternative choice for exchange transfusion in severe HDN due to anti-Rh17 in case that Rh17 antigen-negative blood is unavailable.
|
Authors | Bi-juan Li, Yuan-jun Jiang, Fen Yuan, Hong-xing Ye |
Journal | Transfusion medicine (Oxford, England)
(Transfus Med)
Vol. 20
Issue 1
Pg. 66-9
(Feb 2010)
ISSN: 1365-3148 [Electronic] England |
PMID | 19725902
(Publication Type: Case Reports, Journal Article)
|
Chemical References |
- Immunoglobulins, Intravenous
- Immunosuppressive Agents
- Isoantibodies
- RHO(D) antibody
- Rh-Hr Blood-Group System
- Rho(D) Immune Globulin
- Rho(D) antigen
- Methylprednisolone
|
Topics |
- Adult
- Blood Component Transfusion
(methods)
- Blood Group Incompatibility
(drug therapy, immunology)
- Blood Grouping and Crossmatching
- Erythrocyte Transfusion
- Female
- Humans
- Hydrops Fetalis
(immunology, therapy)
- Hyperbilirubinemia, Neonatal
(etiology, radiotherapy, therapy)
- Immunoglobulins, Intravenous
(therapeutic use)
- Immunosuppressive Agents
(therapeutic use)
- Infant, Newborn
- Isoantibodies
(immunology)
- Leukocyte Reduction Procedures
- Male
- Methylprednisolone
(therapeutic use)
- Plasma
- Pregnancy
- Rh Isoimmunization
- Rh-Hr Blood-Group System
(immunology)
- Rho(D) Immune Globulin
- Ultraviolet Therapy
- Young Adult
|